“Nothing changes,” says 77-year-old Y. K. Hamied, responding to queries on his plans to retire as Cipla Managing Director with effect from March 31. A “momentous day” is how a senior Cipla ...

Cipla chairman and managing director Dr YK Hamied --instrumental in making healthcare affordable by launching copy-cat copies of AIDS, cancer and other life-saving medicines, has decided to call ...

"As Cipla's MD & GCEO, Vohra's priorities have been Cipla's strategic growth, defining and executing Cipla's roadmap to maintain momentum in home markets whilst strengthening its presence in other ...

Torrent Pharma is the most well-placed candidate to acquire the 33% promoter stake in India’s third largest pharma company CIPLA, edging out rival Dr Reddy’s Laboratories and private equity ...

Another US-based PE titan, Bain Capital, was talking to Dr. Reddy’s Laboratories, the second-largest pharma major by sales, about joining hands to acquire Cipla. Hamied chose not to address the ...

While Torrent Pharma, a smaller rival, has emerged as a frontrunner, on the other side, Dr Reddy's Labs was reportedly approached by Bain Capital to make a joint bid for Cipla. The promoters ...